With its acquisition of IntraBio, Shionogi will gain ownership over Aqneursa, which could hit peak global sales of $1 billion across its two indications in Niemann-Pick disease type C and ataxia-telangiectasia, according to Jefferies.
40 Under 40 honorees’ accomplishments include co-developing the world’s first synthetic biology programming language for mRNA and co-founding and leading a company acquired for $700 million up-front and up to $1.225 billion in total consideration.
The Internal Revenue Service’s Criminal Investigation division had to divert considerable resources from its regular work to aid immigration authorities.
The move adds pressure on the accounting giant that has been grappling with the fallout from allegations it improperly used confidential client information.